Comparison of Progressive Cortical Gray Matter Loss in Childhood-Onset Schizophrenia with That in Childhood-Onset Atypical Psychoses

Archives of General Psychiatry

Volumn 61, Issue 1, 2004, Pages 17-22

  Gogtay, Nitin ^a,c   Sporn, Alexandra ^a   Clasen, Liv S ^a   Nugent III, Tom F ^a   Greenstein, Deanna ^a   Nicolson, Rob ^a   Giedd, Jay N ^a   Lenane, Marge ^a   Gochman, Pete ^a   Evans, Alan ^b   Rapoport, Judith L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c Geriatric Psychiatry Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADOLESCENCE; ADOLESCENT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ARTICLE; AUTOMATION; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN DISEASE; BRAIN RADIOGRAPHY; BRAIN REGION; BRAIN SIZE; CALCULATION; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; FRONTAL LOBE; GRAY MATTER; HUMAN; INTELLIGENCE QUOTIENT; MALE; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARIETAL LOBE; PEDIATRICS; PROSPECTIVE STUDY; PSYCHOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TEMPORAL LOBE;

ADOLESCENT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; ATROPHY; CEREBRAL CORTEX; CHILD; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 9144232250     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.61.1.17     Document Type: Article

References (36)

1. Nicolson R, Rapoport JL. Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry. 1999;46:1418-1428.
2. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58:148-157.
3. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59:553-558.
4. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129-140.
5. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55:145-152.
6. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA, Yurgelun-Todd D, Zarate C, Kikinis R, Jolesz FA, McCarley RW. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 1999;156: 1091-1093.
7. Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry. 2001;49:487-499.
8. Wood SJ, Velakoulis D, Smith DJ, Bond D, Stuart GW, McGorry PD, Brewer WJ, Bridle N, Eritaia J, Desmond P, Singh B, Copolov D, Pantelis C. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res. 2001;52:37-46.
9. Rapoport JL, Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, Nelson J, Hamburger S. Childhood-onset schizophrenia: progressive ventricular change during adolescence. Arch Gen Psychiatry. 1997;54:897-903.
10. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicolson R, Bedwell J, Lenane M, Zijdenbos A, Paus T, Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 1999;56:649-654.
11. Gogate N, Giedd J, Janson K, Rapoport JL. Brain imaging in normal and abnormal brain development: new perspectives for child psychiatry. Clin Neurosci Res. 2001;1:283-290.
12. Kumra S, Jacobsen LK, Lenane M, Zahn TP, Wiggs E, Alaghband-Rad J, Castellanos FX, Frazier JA, McKenna K, Gordon CT, Smith A, Hamburger S, Rapoport JL. "Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry. 1998;37:91-99.
13. McKenna K, Gordon CT, Lenane M, Kaysen D, Fahey K, Rapoport JL. Looking for childhood-onset schizophrenia: the first 71 cases screened. J Am Acad Child Adolesc Psychiatry. 1994;33:636-644.
14. Nicolson R, Lenane M, Brookner F, Gochman P, Kumra S, Spechler L, Giedd JN, Thaker GK, Wudarsky M, Rapoport JL. Children and adolescents with psychotic disorder not otherwise specified: a 2- to 8-year follow-up study. Compr Psychiatry. 2001;42:319-325.
15. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, Hamburger SD, Smith AK, Albus KE, Alaghband-Rad J, Rapoport JL. Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry. 1996;53:1090-1097.
16. Giedd JN, Snell JW, Lange N, Rajapakse JC, Casey BJ, Kozuch PL, Vaituzis AC, Vauss YC, Hamburger SD, Kaysen D, Rapoport JL. Quantitative magnetic resonance imaging of human brain development: ages 4-18. Cereb Cortex. 1996;6: 551-560.
17. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL Brain development during childhood and adolescence: a longitudinal MRI study [letter]. Nat Neurosci. 1999;2:861-863.
18. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M. The assessment of affective disorders in children and adolescents by semistructured interview: test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry. 1985;42:696-702.
19. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-D Proportional System: An Approach to Cerebral Imaging. New York, NY: Thieme Medical Publishers; 1988.
20. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ, Evans AC. Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging. 1998;17:463-468.
21. Zijdenbos AP, Dawant BM, Margolin RA. Automatic detection of intracranial contours in MR images. Comput Med Imaging Graph. 1994;18:11-23.
22. Tabachnick BG, Fidell LS. Computer-Assisted Research Design and Analysis. Needham Heights, Mass: Allyn & Bacon; 2001:130-132.
23. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281-285.
24. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000; 48:813-829.
25. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 2001;11:240-249.
26. Andersson C, Hamer RM, Lawler CP, Mailman RB, Lieberman JA. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2002;27:143-151.
27. Lee H, Tarazi FI, Chakos M, Wu H, Redmond M, Alvir JM, Kinon BJ, Bilder R, Creese I, Lieberman JA. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum. Life Sci. 1999;64:1595-1602.
28. Selemon LD, Lidow MS, Goldman-Rakic PS. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry. 1999;46:161-172.
29. Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet. 1995;345:456-457.
30. Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, Lenane MC, McKenna K, Breier A, Rapoport JL. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry. 1996;153:564-566.
31. Sporn AL, Greenstein DK, Gogtay N, Jeffries NO, Lenane M, Gochman P, Clasen LS, Blumenthal J, Giedd JN, Rapoport JL. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry. In press.
32. Fannon D, Chitnis X, Doku V, Tennakoon L, O'Ceallaigh S, Soni W, Sumich A, Lowe J, Santamaria M, Sharma T. Features of structural brain abnormality detected in first-episode psychosis. Am J Psychiatry. 2000;157:1829-1834.
33. Lieberman J, Charles C, McEvoy J, Perkins D, Hamer RM, Sharma T, Zipursky R, Kahn R, Gur R, Centorrino F, Glick I, Green AI, Nemeroff C, Rothchild A, Murray R. Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 8-12, 2002; San Juan, Puerto Rico.
34. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000;48:740-754.
35. Mora A, Gonzalez-Polo RA, Fuentes JM, Soler G, Centeno F. Different mechanisms of protection against apoptosis by valproate and Li+. Eur J Biochem. 1999; 266:886-891.
36. Bedwell JS, Keller B, Smith AK, Hamburger S, Kumra S, Rapoport JL. Why does postpsychotic Itic IQ decline in childhood-onset schizophrenia? Am J Psychiatry. 1999;156:1996-1997.